This inventor holds 2 USPTO granted patents. Top assignees: Health Research, Inc., The University of New Mexico, Other. Active years: 2015-2020.
Company Filing History:
1 out of 313 
1 out of 942 
1 out of 834,350 Years Active: 2015-2020
Title: Oleg Ursu: Innovator in Medical Research
Introduction
Oleg Ursu is a notable inventor based in Albuquerque, NM (US), recognized for his contributions to medical research and innovation. He holds 2 patents that focus on significant advancements in the treatment of various health conditions.
Latest Patents
Ursu's latest patents include "Human GLUT5 specific inhibitors and methods of treatment." This invention relates to compounds that act as potent ligands of human GLUT5, a glucose transporter that plays a crucial role in fructose transport. The patent outlines the potential use of these compounds in treating conditions mediated through GLUT5, such as GLUT5 deficiency syndrome, diabetes, cancer, and metabolic diseases. Another significant patent is "Methods for reducing superoxide anions in eukaryotic organisms." This invention provides methods and compositions aimed at reducing oxidative stress, inflammation, and enhancing the lifespan of eukaryotic organisms.
Career Highlights
Throughout his career, Oleg Ursu has worked with various organizations, including Health Research, Inc. and Stc.unm. His work has significantly impacted the field of medical research, particularly in developing therapeutic methods and compounds.
Collaborations
Ursu has collaborated with notable colleagues such as William C. Burhans and Catherine E. Prudom Gineste. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Oleg Ursu's innovative work in medical research showcases his dedication to improving health outcomes through scientific advancements. His patents reflect a commitment to addressing critical health issues and enhancing the quality of life for many individuals.